Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Tom

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nature Communications|September 6, 2022
Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degenerationStefan Gerhardy, Mark Ultsch, Wanjian Tang, et al.
The AAPS Journal|October 3, 2007
Reproducible production of a PEGylated dual-acting peptide for diabetesIrene Tom, Vivian Lee, Michael Dumas, et al.
Plos One|January 9, 2014
Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptorPatrick C G Haddick, Irene Tom, Elizabeth Luis, et al.
Nature Immunology|November 18, 2008
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cellsXin Yu, Kristin Harden, Lino C Gonzalez, et al.
The Journal of Biological Chemistry|March 1, 2006
Design of a long acting peptide functioning as both a glucagon-like peptide-1 receptor agonist and a glucagon receptor antagonistClark Q Pan, Joanne M Buxton, Stephanie L Yung, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2006
Engineering novel VPAC2-selective agonists with improved stability and glucose-lowering activity in vivoClark Q Pan, Fugang Li, Irene Tom, et al.
Nature Communications|May 6, 2016
The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
Nature Communications|August 22, 2017
Corrigendum: The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
American Journal of Ophthalmology|July 2, 2021
Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular DegenerationArshad M Khanani, Vrinda S Hershberger, Dante J Pieramici, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophyIrene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Communications|September 6, 2022
Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degenerationStefan Gerhardy, Mark Ultsch, Wanjian Tang, et al.
The AAPS Journal|October 3, 2007
Reproducible production of a PEGylated dual-acting peptide for diabetesIrene Tom, Vivian Lee, Michael Dumas, et al.
Plos One|January 9, 2014
Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptorPatrick C G Haddick, Irene Tom, Elizabeth Luis, et al.
Nature Immunology|November 18, 2008
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cellsXin Yu, Kristin Harden, Lino C Gonzalez, et al.
The Journal of Biological Chemistry|March 1, 2006
Design of a long acting peptide functioning as both a glucagon-like peptide-1 receptor agonist and a glucagon receptor antagonistClark Q Pan, Joanne M Buxton, Stephanie L Yung, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2006
Engineering novel VPAC2-selective agonists with improved stability and glucose-lowering activity in vivoClark Q Pan, Fugang Li, Irene Tom, et al.
Nature Communications|May 6, 2016
The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
Nature Communications|August 22, 2017
Corrigendum: The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulationNadia Martinez-Martin, Sree R Ramani, Jason A Hackney, et al.
American Journal of Ophthalmology|July 2, 2021
Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular DegenerationArshad M Khanani, Vrinda S Hershberger, Dante J Pieramici, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophyIrene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Pageof 3